Pagnotti, Gabriel M. https://orcid.org/0000-0003-0888-5117
Trivedi, Trupti
Wright, Laura E.
John, Sutha K.
Murthy, Sreemala
Pattyn, Ryan R.
Willis, Monte S. https://orcid.org/0000-0002-0769-5816
She, Yun
Suresh, Sukanya
Touray, Aji F. https://orcid.org/0009-0006-8255-4497
Thompson, William R. https://orcid.org/0000-0002-7022-585X
Rubin, Clinton T. https://orcid.org/0000-0003-0909-7999
Mohammad, Khalid S.
Guise, Theresa A. https://orcid.org/0009-0006-7026-402X
Funding for this research was provided by:
Indiana Clinical and Translational Sciences Institute (TL1 TR002531)
Indiana Clinical and Translational Sciences Institute (UL1 TR002529)
Lawrence Family Bone Disease Program of Texas
U.S. Department of Defense (W81XWH-16-1-0040)
U.S. Department of Defense (BC150678P1)
Dive Into The Pink; Indiana University School of Medicine Center for Musculoskeletal Health; Peggy S. Throgmartin Endowment; Lawrence Family Bone Disease Program of Texas
Article History
Received: 18 August 2024
Accepted: 28 December 2025
First Online: 21 January 2026
Competing interests
: The authors declare the following competing interests: Dr. Clinton T. Rubin is a founder of Marodyne Medical, LLC and Lahara Bio, LLC and has several patents issued and pending related to the ability of mechanical signals to control musculoskeletal and metabolic disorders.